Aspen Pharma do Brasil could be negotiating acquisition of assets in Brazil
Aspen Pharma do Brasil estaria negociando a compra de ativos no Brasil
Intel ID : 237550
| Synopsis |
|
Aspen Pharma do Brasil, a subsidiary of South Africa-based Aspen Pharma and engaged in the pharmaceutical sector, could be negotiating the acquisition of assets in Brazil, as published by newspaper Valor Econômico on 9 June 2016, citing its executive director, Alexandre França. According to the news, at the moment, two negotiations are underway, under a confidentiality agreement and if one of the deals materializes, Aspen will increase its revenues in excess of 50%. "We are still pending some adjustments, but we are investing in Brazil", said Alexandre França.
(content in portuguese)
Aspen Pharma do Brasil, subsidiária da sul-africana Aspen Pharma que atua no setor farmacêutico, estaria negociando a compra de ativos no Brasil, segundo publicou o Valor Econômico no dia 09 de junho de 2016, citando o principal executivo da farmacêutica no Brasil, Alexandre França. De acordo com a notícia, neste momento, duas negociações estão em andamento, preservadas por acordo de confidencialidade e, se um dos negócios sair, a Aspen crescerá mais de 50% em faturamento. "Ainda dependemos de acertos, mas estamos investindo no país", disse Alexandre França. |
| Intel ID | 237550 | |
| Value | ND | |
| Native Currency |
Brazilian Real (BRL)
Exchange Rate:  |
|
| Date |
|
|
| Country |  |
|
| Region | ||
| Continent | |
|
| Geography | |
|
| Subsector (Old TTR Sectors) |
|
|
| Type |
|
|
| Intel Grade |
|
|
| Source |
|
|
| Tags | |
Bidder
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
30.01.03 Pharmaceutical R&D, Manufacturing & Distribution 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Ultimate Owner (Buyer)
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
30.01.03 Pharmaceutical R&D, Manufacturing & Distribution 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.